EANM实践指南/SNMMI程序标准:帕金森综合征多巴胺能成像1.0版
该指南由欧洲核医学协会(EANM)与核医学与分子影像学会(SNMMI)联合制定,旨在帮助核医学从业者在帕金森综合征的多巴胺能成像中进行推荐、执行、解读和报告。方法部分回顾了既往SPECT多巴胺转运体成像和D2 SPECT成像指南,并整合了半定量化、协调化、与正常数据集比较、纵向分析以及PET多巴胺转运体成像(包括氟化示踪剂)和[18F]氟多巴PET的新证据。结论指出本程序指南涵盖了这些新出现的问题。
要点
- EANM与SNMMI联合发布帕金森综合征多巴胺能成像实践指南/程序标准1.0版。
- 指南整合了SPECT多巴胺转运体成像的半定量化、协调化及纵向分析新证据。
- 指南涵盖PET多巴胺转运体成像(含氟化示踪剂)及[18F]氟多巴PET的程序细节。
核心结论
- 本程序指南针对帕金森综合征多巴胺能成像中半定量化、协调化、与正常数据集比较、纵向分析、PET采集协议与简化定量方法以及[18F]氟多巴PET等新出现问题进行了阐述。
研究设计与样本
- 由欧洲核医学协会(EANM)与核医学与分子影像学会(SNMMI)联合制定的实践指南/程序标准。
主要发现
- EANM和SNMMI分别于2009年和2011年发布了SPECT多巴胺转运体成像程序指南,EANM还于2009年发布了D2 SPECT成像指南。
- 自既往指南发布以来,出现了关于SPECT多巴胺转运体成像半定量化、协调化、与正常数据集比较及纵向分析的新证据。
- PET多巴胺转运体成像(包括新开发的氟化示踪剂)的采集协议和简化定量方法细节现已可用。
- 部分中心现已使用[18F]氟多巴PET用于帕金森综合征的鉴别诊断,但尚缺乏针对该场景定义标准程序的程序指南。
局限性
- 原文指出,旨在定义[18F]氟多巴成像标准程序的程序指南仍然缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This joint practice guideline or procedure standard was developed collaboratively by the European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). The goal of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of dopaminergic imaging in parkinsonian syndromes. METHODS: Currently nuclear medicine investigations can assess both presynaptic and postsynaptic function of dopaminergic synapses. To date both EANM and SNMMI have published procedural guidelines for dopamine transporter imaging with single photon emission computed tomography (SPECT) (in 2009 and 2011, respectively). An EANM guideline for D2 SPECT imaging is also available (2009). Since the publication of these previous guidelines, new lines of evidence have been made available on semiquantification, harmonization, comparison with normal datasets, and longitudinal analyses of dopamine transporter imaging with SPECT. Similarly, details on acquisition protocols and simplified quantification methods are now available for dopamine transporter imaging with PET, including recently developed fluorinated tracers. Finally, [18F]fluorodopa PET is now used in some centers for the differential diagnosis of parkinsonism, although procedural guidelines aiming to define standard procedures for [18F]fluorodopa imaging in this setting are still lacking. CONCLUSION: All these emerging issues are addressed in the present procedural guidelines for dopaminergic imaging in parkinsonian syndromes.
引用
- Morbelli S, Esposito G, Arbizu J, et al. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. Eur J Nucl Med Mol Imaging. 2020. PMID: 32388612. doi:10.1007/s00259-020-04817-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。